CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Historical Holders from Q4 2015 to Q2 2025

Symbol
CTMX on Nasdaq
CUSIP
23284F105
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
164M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
133M
Holdings value
$303M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
82
Number of buys
55
Number of sells
-29
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Venrock Healthcare Capital Partners III, L.P. 8.2% $9.22M 13M Venrock Healthcare Capital Partners III, L.P. May 13, 2025
Longitude Capital Partners V, LLC 7.3% $8.19M 11.5M Longitude Capital Partners V, LLC May 13, 2025
TANG CAPITAL MANAGEMENT LLC 7% -17.5% $22.1M $8.7M 11.1M +64.7% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
PERCEPTIVE ADVISORS LLC 5.9% $19.4M 9.68M Perceptive Advisors LLC Aug 14, 2025
VANGUARD GROUP INC 5.95% $23.4M 9.38M The Vanguard Group Jun 30, 2025
FMR LLC 5.9% $23.1M 9.24M FMR LLC Jun 30, 2025
ORBIMED ADVISORS LLC 5.4% $16.9M 8.46M OrbiMed Advisors LLC Jun 30, 2025
Point72 Asset Management, L.P. 5.1% -40% $16.2M -$10M 8.08M -38.3% Point72 Asset Management, L.P. Jun 30, 2025
BIOTECHNOLOGY VALUE FUND L P 3.5% -47.1% $14.4M -$14.4M 5.77M -50% BVF PARTNERS L P/IL Jul 3, 2025
Seven Fleet Partners LP 0.2% $268K 377K Seven Fleet Partners LP May 13, 2025

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 133M $303M +$214M $2.27 82
2025 Q1 45.2M $28.7M -$1.51M $0.64 63
2024 Q4 46.7M $48.1M -$6.38M $1.03 68
2024 Q3 51.2M $60.4M +$481K $1.18 70
2024 Q2 50.7M $61.9M +$882K $1.22 73
2024 Q1 44.5M $97.1M +$24.3M $2.18 86
2023 Q4 31.5M $48.8M +$392K $1.55 64
2023 Q3 31.3M $40.3M -$2.41M $1.29 60
2023 Q2 34.1M $58.7M -$2.38M $1.72 65
2023 Q1 34.5M $52M -$652K $1.51 72
2022 Q4 34.6M $55.4M -$51.5K $1.60 75
2022 Q3 36.3M $52.6M -$18.7M $1.45 74
2022 Q2 45.2M $82.7M -$18.5M $1.83 85
2022 Q1 53.7M $143M -$1.36M $2.67 111
2021 Q4 54.2M $235M -$5.21M $4.33 104
2021 Q3 53.9M $274M -$13M $5.09 110
2021 Q2 55.8M $353M -$141K $6.33 115
2021 Q1 54.6M $422M +$131M $7.73 124
2020 Q4 37.9M $248M +$6.77M $6.55 122
2020 Q3 36.8M $245M -$11.5M $6.65 127
2020 Q2 37.7M $314M +$28.2M $8.33 130
2020 Q1 36.1M $277M +$523K $7.67 110
2019 Q4 35.7M $297M -$9.66M $8.31 116
2019 Q3 35.8M $264M +$884K $7.38 110
2019 Q2 35.6M $400M -$8.08M $11.22 108
2019 Q1 36.7M $394M -$12.8M $10.75 105
2018 Q4 37.5M $567M +$45.7K $15.10 104
2018 Q3 37.7M $697M +$95.6M $18.50 117
2018 Q2 32.1M $734M +$67M $22.86 137
2018 Q1 28.6M $813M +$71.8M $28.45 134
2017 Q4 30M $634M +$55.5M $21.11 118
2017 Q3 24.2M $441M +$43M $18.17 97
2017 Q2 22.1M $343M +$44.9M $15.50 87
2017 Q1 19.2M $331M +$57.7M $17.27 85
2016 Q4 16.9M $185M +$15M $10.99 68
2016 Q3 15.5M $243M +$18.1M $15.68 60
2016 Q2 14.6M $149M +$16M $10.21 56
2016 Q1 12.8M $164M +$3.31M $12.90 45
2015 Q4 12.5M $258M +$240M $20.87 46